These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17892078)

  • 21. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital fecal occult blood testing in the ambulatory urology clinic.
    Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
    J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is routine fecal occult blood testing worthwhile in hospitalized patients?
    Anthea N; Afroze M; Richard W
    Md Med J; 1994 May; 43(5):443-5. PubMed ID: 8052096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoting fecal occult blood testing in rural African American women.
    Powe BD
    Cancer Pract; 2002; 10(3):139-46. PubMed ID: 11972568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.
    Collins JF; Lieberman DA; Durbin TE; Weiss DG;
    Ann Intern Med; 2005 Jan; 142(2):81-5. PubMed ID: 15657155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal occult blood test use by Kansas medicare beneficiaries.
    Engelman KK; Ellerbeck EF; Ahluwalia JS; Nazir N; Velasco A
    Prev Med; 2001 Dec; 33(6):622-6. PubMed ID: 11716659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
    Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
    Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utilization of fecal occult blood testing in the institutionalized elderly.
    Klos SE; Drinka P; Goodwin JS
    J Am Geriatr Soc; 1991 Dec; 39(12):1169-73. PubMed ID: 1960360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel indicator for surveillance colonoscopy following colorectal cancer resection.
    Skaife P; Seow-Choen F; Eu KW; Tang CL
    Colorectal Dis; 2003 Jan; 5(1):45-8. PubMed ID: 12780926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
    Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic approach to evaluating the cause of a positive fecal occult blood test.
    Stroehlein JR; Goulston K; Hunt RH
    CA Cancer J Clin; 1984; 34(3):148-57. PubMed ID: 6426711
    [No Abstract]   [Full Text] [Related]  

  • 37. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
    Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
    J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
    van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
    Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count?
    Eisner MS; Lewis JH
    Arch Intern Med; 1991 Nov; 151(11):2180-4. PubMed ID: 1953220
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.